We are live on ! Find out more
NVNO

enVVeno Medical

7 hedge funds and large institutions have $397K invested in enVVeno Medical in 2020 Q4 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

305% more capital invested

Capital invested by funds: $98K → $397K (+$299K)

25% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 4

17% more funds holding

Funds holding: 67 (+1)

0.05% more ownership

Funds ownership: 0%0.05% (+0.05%)

Holders
7
Holders Change
+1
Holders Change %
+16.67%
% of All Funds
0.12%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
Reduced
Closed
4
Calls
Puts
Net Calls
Net Calls Change

NVNO Hedge Fund Activity: Q4 2020 in Review

7 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in enVVeno Medical (NVNO) for Q4 2020, worth a combined $397K — up 305% from $98K a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new NVNO positions and 4 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Virtu Financial, opening a new position worth an estimated $231K. The largest seller was Citadel Advisors, exiting entirely with an estimated $56K sold.

  • 7 institutional investors held enVVeno Medical (NVNO) as of Q4 2020, up from 6 in Q3 2020.
  • Funds reported $397K of enVVeno Medical stock for Q4 2020, up 305% quarter-over-quarter.
  • 5 funds opened new enVVeno Medical positions in Q4 2020 and 4 closed out, a net change of +1 holder.
  • The largest enVVeno Medical buyer in Q4 2020 was Virtu Financial, an estimated $231K added.
  • The largest enVVeno Medical seller in Q4 2020 was Citadel Advisors, an estimated $56K sold.

Based on aggregated 13F filings for Q4 2020.